Literature DB >> 7857150

Patients with soft-tissue sarcomas.

P F Choong, A Rydholm, P Gustafson.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7857150      PMCID: PMC1234958     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.

Authors:  S Singer; J M Corson; R Gonin; B Labow; T J Eberlein
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

2.  Mitosis counting--a need for reappraisal.

Authors:  P S Ellis; R Whitehead
Journal:  Hum Pathol       Date:  1981-01       Impact factor: 3.466

3.  Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 consecutive cases.

Authors:  O M Jensen; J Høgh; S E Ostgaard; A M Nordentoft; O Sneppen
Journal:  J Pathol       Date:  1991-01       Impact factor: 7.996

4.  Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content.

Authors:  P Gustafson; H Willén; B Baldetorp; M Fernö; M Akerman; A Rydholm
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

5.  Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study.

Authors:  H Hashimoto; Y Daimaru; M Tsuneyoshi; M Enjoji
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

6.  Prognostic significance of histologic parameters of soft tissue sarcomas.

Authors:  H Hashimoto; Y Daimaru; S Takeshita; M Tsuneyoshi; M Enjoji
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

7.  Prognostic factors for survival in soft tissue sarcoma.

Authors:  J N el-Jabbour; S S Akhtar; G R Kerr; K M McLaren; J F Smyth; A Rodger; R C Leonard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

  7 in total
  2 in total

1.  Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization.

Authors:  Yasuko Nakagawa; Kunihiko Numoto; Aki Yoshida; Toshiyuki Kunisada; Hidenori Ohata; Ken Takeda; Daniel Wai; Christopher Poremba; Toshifumi Ozaki
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-24       Impact factor: 4.553

2.  Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma.

Authors:  Xiaoyang Li; Nicole A Seebacher; Cassandra Garbutt; Hangzhan Ma; Peng Gao; Tao Xiao; Francis J Hornicek; Zhenfeng Duan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.